匯盈控股(00821.HK):配售協議失效
格隆匯5月29日丨匯盈控股(00821.HK)發佈公吿,由於股份配售協議(經附錄、第二份附錄、第三份附錄及第四份附錄所修訂及補充)所載的先決條件於2024年5月29日(即股份交割日期)前尚未獲全面達成或滿足,故股份配售協議已吿失效,而股份配售將不會進行。配售代理及公司於股份配售協議項下的所有義務及責任即時停止及終止,而股份配售訂約方將不得向其他股份配售訂約方就股份配售協議提出任何申索(惟先前違反配售協議的任何事項除外),且不會損害各股份配售訂約方已產生的權利及責任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.